1
|
Du N, Yang R, Jiang S, Niu Z, Zhou W, Liu C, Gao L, Sun Q. Anti-Aging Drugs and the Related Signal Pathways. Biomedicines 2024; 12:127. [PMID: 38255232 PMCID: PMC10813474 DOI: 10.3390/biomedicines12010127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Revised: 12/16/2023] [Accepted: 12/27/2023] [Indexed: 01/24/2024] Open
Abstract
Aging is a multifactorial biological process involving chronic diseases that manifest from the molecular level to the systemic level. From its inception to 31 May 2022, this study searched the PubMed, Web of Science, EBSCO, and Cochrane library databases to identify relevant research from 15,983 articles. Multiple approaches have been employed to combat aging, such as dietary restriction (DR), exercise, exchanging circulating factors, gene therapy, and anti-aging drugs. Among them, anti-aging drugs are advantageous in their ease of adherence and wide prevalence. Despite a shared functional output of aging alleviation, the current anti-aging drugs target different signal pathways that frequently cross-talk with each other. At present, six important signal pathways were identified as being critical in the aging process, including pathways for the mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), nutrient signal pathway, silent information regulator factor 2-related enzyme 1 (SIRT1), regulation of telomere length and glycogen synthase kinase-3 (GSK-3), and energy metabolism. These signal pathways could be targeted by many anti-aging drugs, with the corresponding representatives of rapamycin, metformin, acarbose, nicotinamide adenine dinucleotide (NAD+), lithium, and nonsteroidal anti-inflammatory drugs (NSAIDs), respectively. This review summarized these important aging-related signal pathways and their representative targeting drugs in attempts to obtain insights into and promote the development of mechanism-based anti-aging strategies.
Collapse
Affiliation(s)
- Nannan Du
- Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China; (N.D.); (R.Y.); (Z.N.); (W.Z.); (C.L.); (L.G.)
- Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, Beijing 100071, China
| | - Ruigang Yang
- Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China; (N.D.); (R.Y.); (Z.N.); (W.Z.); (C.L.); (L.G.)
- Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, Beijing 100071, China
- Nanhu Laboratory, Jiaxing 314002, China
| | - Shengrong Jiang
- The Meta-Center, 29 Xierqi Middle Rd, Beijing 100193, China;
| | - Zubiao Niu
- Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China; (N.D.); (R.Y.); (Z.N.); (W.Z.); (C.L.); (L.G.)
- Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, Beijing 100071, China
- Nanhu Laboratory, Jiaxing 314002, China
| | - Wenzhao Zhou
- Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China; (N.D.); (R.Y.); (Z.N.); (W.Z.); (C.L.); (L.G.)
- Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, Beijing 100071, China
| | - Chenyu Liu
- Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China; (N.D.); (R.Y.); (Z.N.); (W.Z.); (C.L.); (L.G.)
- Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
| | - Lihua Gao
- Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China; (N.D.); (R.Y.); (Z.N.); (W.Z.); (C.L.); (L.G.)
| | - Qiang Sun
- Frontier Biotechnology Laboratory, Beijing Institute of Biotechnology, Beijing 100071, China; (N.D.); (R.Y.); (Z.N.); (W.Z.); (C.L.); (L.G.)
- Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, Beijing 100071, China
- Nanhu Laboratory, Jiaxing 314002, China
| |
Collapse
|
2
|
Yang Y, Xie Z, Hu H, Yang G, Zhu X, Yang D, Niu Z, Mao G, Shao M, Wang J. Using CT imaging features to predict visceral pleural invasion of non-small-cell lung cancer. Clin Radiol 2023; 78:e909-e917. [PMID: 37666721 DOI: 10.1016/j.crad.2023.08.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Revised: 08/07/2023] [Accepted: 08/09/2023] [Indexed: 09/06/2023]
Abstract
AIM To examine the diagnostic performance of different models based on computed tomography (CT) imaging features in differentiating the invasiveness of non-small-cell lung cancer (NSCLC) with multiple pleural contact types. MATERIALS AND METHODS A total of 1,573 patients with NSCLC (tumour size ≤3 cm) were included retrospectively. The clinical and pathological data and preoperative imaging features of these patients were investigated and their relationships with visceral pleural invasion (VPI) were compared statistically. Multivariate logistic regression was used to eliminate confounding factors and establish different predictive models. RESULTS By univariate analysis and multivariable adjustment, surgical history, tumour marker (TM), number of pleural tags, length of solid contact and obstructive inflammation were identified as independent risk predictors of pleural invasiveness (p=0.014, 0.003, <0.001, <0.001, and 0.017, respectively). In the training group, comparison of the diagnostic efficacy between the combined model including these five independent predictors and the image feature model involving the latter three imaging predictors were as follows: sensitivity of 88.9% versus 77% and specificity of 73.5% versus 84.1%, with AUC of 0.868 (95% CI: 0.848-0.886) versus 0.862 (95% CI: 0.842-0.880; p=0.377). In the validation group, the sensitivity and specificity of these two models were as follow: the combined model, 93.5% and 74.3%, the imaging feature model, 77.4% and 81.3%, and their areas under the curve (AUCs) were both 0.884 (95% CI: 0.842-0.919). The best cut-off value of length of solid contact was 7.5 mm (sensitivity 68.9%, specificity 75.5%). CONCLUSIONS The image feature model showed great potential in predicting pleural invasiveness, and had comparable diagnostic efficacy compared with the combined model containing clinical data.
Collapse
Affiliation(s)
- Y Yang
- Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China; Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, China
| | - Z Xie
- Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China
| | - H Hu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - G Yang
- Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, China
| | - X Zhu
- Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, China
| | - D Yang
- Department of Radiology, Taizhou Municipal Hospital, Taizhou, China
| | - Z Niu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - G Mao
- Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, China
| | - M Shao
- Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, China
| | - J Wang
- Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, China.
| |
Collapse
|
3
|
Hu T, Feng P, Li H, Zhou L, Niu Z, Huang Y, Wang X, Wang C, Liu H, Wu C. [Rac1 promotes the formation of heterotypic cell-in-cell structure]. Sheng Wu Gong Cheng Xue Bao 2023; 39:4123-4134. [PMID: 37877395 DOI: 10.13345/j.cjb.230091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 10/26/2023]
Abstract
Heterotypic cell-in-cell structures (heCICs) are closely related to tumor development and progression, and have become a new frontier in life science research. Ras-related C3 botulinum toxin substrate 1 (Rac1) belongs to the classic Rho GTPase, which plays a key role in regulating the cytoskeleton and cell movement. To investigate the role and mechanism of Rac1 in the formation of heCICs, tumor cells and immune killer cells were labeled with cell-tracker, respectively, to establish the heCICs model. Upon treatment with the Rac1 inhibitor NSC23766, the formation of heCICs between tumor and immune cells was significantly reduced. The plasmid pQCXIP-Rac1-EGFP constructed by gene cloning was packaged into pseudoviruses that subsequently infect tumor cells to make cell lines stably expressing Rac1. As a result, the formation of heCICs was significantly increased upon Rac1 overexpression. These results demonstrated a promotive role of Rac1 in heCICs formation, which may facilitate treating cell-in-cell related diseases, such as tumors, by targeting Rac1.
Collapse
Affiliation(s)
- Tao Hu
- School of Biomedical Engineering, Dalian University of Technology, Dalian 116024, Liaoning, China
- Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
| | - Pengfei Feng
- Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
- Chinese People's Liberation Army Medical School, Beijing 100853, China
- Beijing Key Laboratory of Aging and Geriatrics, Institute of Geriatrics, the 2nd Medical Center, China National Clinical Research Center for Geriatric Disease, Chinese People's Liberation Army General Hospital, Beijing 100853, China
| | - Haoyuan Li
- School of Biomedical Engineering, Dalian University of Technology, Dalian 116024, Liaoning, China
- Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
| | - Lulin Zhou
- Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
- Department of Geriatric Hematology and Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
| | - Zubiao Niu
- Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
| | - Yinuo Huang
- Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
- Beijing Key Laboratory of Therapeutics Vaccines, Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing 100038, China
| | - Xiaoning Wang
- Chinese People's Liberation Army Medical School, Beijing 100853, China
- Beijing Key Laboratory of Aging and Geriatrics, Institute of Geriatrics, the 2nd Medical Center, China National Clinical Research Center for Geriatric Disease, Chinese People's Liberation Army General Hospital, Beijing 100853, China
| | - Chenxi Wang
- Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
| | - Hui Liu
- School of Biomedical Engineering, Dalian University of Technology, Dalian 116024, Liaoning, China
| | - Chengjun Wu
- School of Biomedical Engineering, Dalian University of Technology, Dalian 116024, Liaoning, China
| |
Collapse
|
4
|
Wei Y, Niu Z, Hou X, Liu M, Wang Y, Zhou Y, Wang C, Ma Q, Zhu Y, Gao X, Li P, Gao S, Zhan S, Yang Z, Tai Y, Shao Q, Ge J, Hua J, Gao L, Sun Q, Jiang H, Huang H. Subtype-based analysis of cell-in-cell structures in non-small cell lung cancer. Am J Cancer Res 2023; 13:1091-1102. [PMID: 37034205 PMCID: PMC10077035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Accepted: 02/16/2023] [Indexed: 04/11/2023] Open
Abstract
Lung cancer is ranked as the leading cause of cancer-related death worldwide, and the development of novel biomarkers is helpful to improve the prognosis of non-small cell lung cancer (NSCLC). Cell-in-cell structures (CICs), a novel functional surrogate of complicated cell behaviors, have shown promise in predicting the prognosis of cancer patients. However, the CIC profiling and its prognostic value remain unclear in NSCLC. In this study, we retrospectively explored the CIC profiling in a cohort of NSCLC tissues by using the "Epithelium-Macrophage-Leukocyte" (EML) method. The distribution of CICs was examined by the Chi-square test, and univariate and multivariate analyses were performed for survival analysis. Four types of CICs were identified in lung cancer tissues, namely, tumor-in-tumor (TiT), tumor-in-macrophage (TiM), lymphocyte-in-tumor (LiT), and macrophage-in-tumor (MiT). Among them, the latter three constituted the heterotypic CICs (heCICs). Overall, CICs were more frequently present in adenocarcinoma than in squamous cell carcinoma (P = 0.009), and LiT was more common in the upper lobe of the lung compared with other lobes (P = 0.020). In univariate analysis, the presence of TiM, heCIC density, TNM stage, T stage, and N stage showed association with the overall survival (OS) of NSCLC patients. Multivariate analysis revealed that heCICs (HR = 2.6, 95% CI 1.25-5.6) and lymph node invasion (HR = 2.6, 95% CI 1.33-5.1) were independent factors associated with the OS of NSCLC. Taken together, we profiled the CIC subtypes in NSCLC for the first time and demonstrated the prognostic value of heCICs, which may serve as a type of novel functional markers along with classical pathological factors in improving prognosis prediction for patients with NSCLC.
Collapse
Affiliation(s)
- Yuexian Wei
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong UniversityBeijing 100044, China
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Xinyu Hou
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical UniversityBeijing 100038, China
| | - Mengzhe Liu
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong UniversityBeijing 100044, China
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Yuqi Wang
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong UniversityBeijing 100044, China
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Yongan Zhou
- Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Military Medical UniversityXi’an 710032, Shaanxi, China
| | - Chenxi Wang
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Qunfeng Ma
- Department of Thoracic Surgery, The Fifth Medical Center of Chinese PLA General HospitalBeijing 100071, China
| | - Yichao Zhu
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Xinyue Gao
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Peiyun Li
- School of Science, Beijing Jiaotong UniversityBeijing 100044, China
| | - Shuo Gao
- School of Science, Beijing Jiaotong UniversityBeijing 100044, China
| | - Sibo Zhan
- School of Science, Beijing Jiaotong UniversityBeijing 100044, China
| | - Zi Yang
- School of Science, Beijing Jiaotong UniversityBeijing 100044, China
| | - Yanhong Tai
- Department of Pathology, The Fifth Medical Center of Chinese PLA General HospitalBeijing 100071, China
| | - Qiuju Shao
- Department of Radiotherapy, The Second Affiliated Hospital of Air Force Military Medical UniversityXi’an 710032, China
| | - Jianlin Ge
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong UniversityBeijing 100044, China
| | - Jilei Hua
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong UniversityBeijing 100044, China
| | - Lihua Gao
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Qiang Sun
- Laboratory of Cell Engineering, Beijing Institute of BiotechnologyBeijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences (2021RU008)Beijing 100071, China
| | - Hong Jiang
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong UniversityBeijing 100044, China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical UniversityBeijing 100038, China
| |
Collapse
|
5
|
Min L, Liu N, Zhou Y, Niu Z. 1220P Efficacy and safety of camrelizumab combined with FLOT versus FLOT alone as neoadjuvant therapy in patients with resectable locally advanced gastric and gastroesophageal junction adenocarcinoma who received D2 radical gastrectomy. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
6
|
Shen L, Gong J, Niu Z, Zhao R, L. Chen, L. Liu, Deng T, L. Lu, Zhang Y, Z. Li, X. Li, B. Xia. 1210P The preliminary efficacy and safety of KN026 combined with KN046 treatment in HER2-positive locally advanced unresectable or metastatic gastric/gastroesophageal junction cancer without prior systemic treatment in a phase II study. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
7
|
Tang M, Su Y, Zhao W, Niu Z, Ruan B, Li Q, Zheng Y, Wang C, Zhang B, Zhou F, Wang X, Huang H, Shi H, Sun Q. AIM-CICs: an automatic identification method for cell-in-cell structures based on convolutional neural network. J Mol Cell Biol 2022; 14:6649212. [PMID: 35869978 PMCID: PMC9701057 DOI: 10.1093/jmcb/mjac044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 04/01/2022] [Accepted: 07/20/2022] [Indexed: 11/14/2022] Open
Abstract
Edited by Luonan Chen Whereas biochemical markers are available for most types of cell death, current studies on non-autonomous cell death by entosis rely strictly on the identification of cell-in-cell structures (CICs), a unique morphological readout that can only be quantified manually at present. Moreover, the manual CIC quantification is generally over-simplified as CIC counts, which represents a major hurdle against profound mechanistic investigations. In this study, we take advantage of artificial intelligence technology to develop an automatic identification method for CICs (AIM-CICs), which performs comprehensive CIC analysis in an automated and efficient way. The AIM-CICs, developed on the algorithm of convolutional neural network, can not only differentiate between CICs and non-CICs (the area under the receiver operating characteristic curve (AUC) > 0.99), but also accurately categorize CICs into five subclasses based on CIC stages and cell number involved (AUC > 0.97 for all subclasses). The application of AIM-CICs would systemically fuel research on CIC-mediated cell death, such as high-throughput screening.
Collapse
Affiliation(s)
| | | | | | | | - Banzhan Ruan
- Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China
| | - Qinqin Li
- Beijing Shijitan Hospital of Capital Medical University, Beijing 100038, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China
| | - Chenxi Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China
| | - Bo Zhang
- Beijing Shijitan Hospital of Capital Medical University, Beijing 100038, China,Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2021RU008, Beijing 100071, China
| | - Fuxiang Zhou
- Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Clinical Cancer Study Center, Zhongnan Hospital, Wuhan University, Wuhan 430071, China
| | - Xiaoning Wang
- National Clinic Center of Geriatric & State Key Laboratory of Kidney, Chinese PLA General Hospital, Beijing 100853, China
| | | | | | - Qiang Sun
- Correspondence to: Qiang Sun, E-mail:
| |
Collapse
|
8
|
Liu CX, Zhang JM, Niu Z, Ni Y, Liu Y. [Analysis of the application of radiotherapy facility construction project evaluation standard in health management institutions]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2022; 40:518-522. [PMID: 35915943 DOI: 10.3760/cma.j.cn121094-20210607-00282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To investigate the application of GBZ/T 220.2-2009 "The Specification of Radiological Protection Assessment for Occupational Hazard in Construction Project-Part 2: Radiotherapy Facility" in health management institutions, and to understand the scientificity, practicability and problems existing in the implementation of the standard. Methods: The method of multistage stratified sampling and questionnaire survey were used to collect the standard application status among 96 radiological health managers who had participated in the evaluation of radiotherapy facility construction projects in 6 provinces and cities from November 2020 to April 2021. A descriptive statistical analysis method was used to analyze the basic information of the survey object, the knowledge of the standard, the publicity and implementation of the standard. Results: The radiological health management personnel mainly came from health supervision agencies (62.5%, 60/96) , and 86.5% (83/96) were engaged in the pre-evaluation of radiotherapy device construction project and the approval and supervision of control effect evaluation. The awareness rate and training rate of radiological health managers on GBZ/T 220.2-2009 were 88.5% (85/96) and 31.3% (30/96) , respectively. 89.6% (86/96) managers thought it could meet the needs of radiotherapy facility construction project approval or supervision. 49.0% (47/96) of managers believed that the standard needed to be revised. Conclusion: The content of GBZ/T 220.2-2009 is basically scientific and reasonable, but the publicity, implementation and training of radiological health administrator still need to be strengthened. It is suggested to revise some clauses in the standard that do not meet the requirements.
Collapse
Affiliation(s)
- C X Liu
- Institute for Occupational Health, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| | - J M Zhang
- Institute for Occupational Health, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| | - Z Niu
- Institute for Occupational Health, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| | - Y Ni
- Institute for Occupational Health, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| | - Y Liu
- Institute for Occupational Health, Tianjin Centers for Disease Control and Prevention, Tianjin 300011, China
| |
Collapse
|
9
|
Zhu Y, Zhou W, Niu Z, Sun J, Zhang Z, Li Q, Zheng Y, Wang C, Gao L, Sun Q. Long-range enhancement of N501Y-endowed mouse infectivity of SARS-CoV-2 by the non-RBD mutations of Ins215KLRS and H655Y. Biol Direct 2022; 17:14. [PMID: 35658928 PMCID: PMC9167559 DOI: 10.1186/s13062-022-00325-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2022] [Accepted: 05/13/2022] [Indexed: 11/28/2022] Open
Abstract
Background Rodents, such as mice, are vulnerable targets, and potential intermediate hosts, of SARS-CoV-2 variants of concern, including Alpha, Beta, Gamma, and Omicron. N501Y in the receptor-binding domain (RBD) of Spike protein is the key mutation dictating the mouse infectivity, on which the neighboring mutations within RBD have profound impacts. However, the impacts of mutations outside RBD on N501Y-mediated mouse infectivity remain to be explored. Results Herein, we report that two non-RBD mutations derived from mouse-adapted strain, Ins215KLRS in the N-terminal domain (NTD) and H655Y in the subdomain linking S1 to S2, enhance mouse infectivity in the presence of N501Y mutation, either alone or together. This is associated with increased interaction of Spike with mouse ACE2 and mutations-induced local conformation changes in Spike protein. Mechanistically, the H655Y mutation disrupts interaction with N657, resulting in a less tight loop that wraps the furin-cleavage finger; and the insertion of 215KLRS in NTD increases its intramolecular interaction with a peptide chain that interfaced with the RBD-proximal region of the neighboring protomer, leading to a more flexible RBD that facilitates receptor binding. Moreover, the Omicron Spike that contains Ins214EPE and H655Y mutations confer mouse infectivity > 50 times over the N501Y mutant, which could be effectively suppressed by mutating them back to wild type. Conclusions Collectively, our study sheds light on the cooperation between distant Spike mutations in promoting virus infectivity, which may undermine the high infectiousness of Omicron variants towards mice. Supplementary information The online version contains supplementary material available at 10.1186/s13062-022-00325-x.
Collapse
|
10
|
Li Q, Wang Y, Sun Q, Knopf J, Herrmann M, Lin L, Jiang J, Shao C, Li P, He X, Hua F, Niu Z, Ma C, Zhu Y, Ippolito G, Piacentini M, Estaquier J, Melino S, Weiss FD, Andreano E, Latz E, Schultze JL, Rappuoli R, Mantovani A, Mak TW, Melino G, Shi Y. Immune response in COVID-19: what is next? Cell Death Differ 2022; 29:1107-1122. [PMID: 35581387 PMCID: PMC9110941 DOI: 10.1038/s41418-022-01015-x] [Citation(s) in RCA: 52] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2022] [Revised: 04/16/2022] [Accepted: 04/26/2022] [Indexed: 12/18/2022] Open
Abstract
The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future. ![]()
Collapse
Affiliation(s)
- Qing Li
- The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China
| | - Ying Wang
- CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
| | - Qiang Sun
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2021RU008, 20 Dongda Street, 100071, Beijing, China
| | - Jasmin Knopf
- Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.,Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany
| | - Martin Herrmann
- Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.,Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany
| | - Liangyu Lin
- CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China
| | - Jingting Jiang
- The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China
| | - Changshun Shao
- The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China
| | - Peishan Li
- The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China
| | - Xiaozhou He
- The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China
| | - Fei Hua
- The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China
| | - Zubiao Niu
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2021RU008, 20 Dongda Street, 100071, Beijing, China
| | - Chaobing Ma
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2021RU008, 20 Dongda Street, 100071, Beijing, China
| | - Yichao Zhu
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2021RU008, 20 Dongda Street, 100071, Beijing, China
| | | | - Mauro Piacentini
- Department of Biology, TOR, University of Rome Tor Vergata, 00133, Rome, Italy
| | - Jerome Estaquier
- INSERM-U1124, Université Paris, Paris, France.,CHU de Québec - Université Laval Research Center, Québec City, QC, Canada
| | - Sonia Melino
- Department of Biology, TOR, University of Rome Tor Vergata, 00133, Rome, Italy
| | - Felix Daniel Weiss
- Institute of Innate Immunity, University Hospital Bonn, University of Bonn, 53127, Bonn, Germany
| | - Emanuele Andreano
- Research and Development Center, GlaxoSmithKline (GSK), Siena, Italy
| | - Eicke Latz
- Institute of Innate Immunity, University Hospital Bonn, University of Bonn, 53127, Bonn, Germany.,Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany
| | - Joachim L Schultze
- Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany.,Genomics & Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany
| | - Rino Rappuoli
- Research and Development Center, GlaxoSmithKline (GSK), Siena, Italy
| | - Alberto Mantovani
- Department of Biomedical Sciences, Humanitas University, via Rita Levi Montalcini 4, Pieve Emanuele, 20072, Milan, Italy.,IRCCS Humanitas Clinical Research Hospital, via Manzoni 56, Rozzano, 20089, Milan, Italy.,William Harvey Research Institute, Queen Mary University, London, UK
| | - Tak Wah Mak
- Princess Margaret Cancer Centre, University Health Network, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.,Department of Pathology, University of Hong Kong, Hong Kong, Pok Fu Lam, 999077, Hong Kong
| | - Gerry Melino
- Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Bonn, Germany. .,Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy.
| | - Yufang Shi
- The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, State Key Laboratory of Radiation Medicine and Protection, Institutes for Translational Medicine of Soochow University, Medical College, Suzhou, China. .,CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences/Shanghai Jiao Tong University School of Medicine, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China. .,Department of Experimental Medicine, TOR, University of Rome Tor Vergata, 00133, Rome, Italy.
| |
Collapse
|
11
|
Su Y, Huang H, Luo T, Zheng Y, Fan J, Ren H, Tang M, Niu Z, Wang C, Wang Y, Zhang Z, Liang J, Ruan B, Gao L, Chen Z, Melino G, Wang X, Sun Q. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Cell Discov 2022; 8:35. [PMID: 35436988 PMCID: PMC9016064 DOI: 10.1038/s41421-022-00387-1] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2021] [Accepted: 01/28/2022] [Indexed: 12/30/2022] Open
Abstract
Penetration of immune cells into tumor cells was believed to be immune-suppressive via cell-in-cell (CIC) mediated death of the internalized immune cells. We unexpectedly found that CIC formation largely led to the death of the host tumor cells, but not the internalized immune cells, manifesting typical features of death executed by NK cells; we named this “in-cell killing” which displays the efficacy superior to the canonical way of “kiss-killing” from outside. By profiling isogenic cells, CD44 on tumor cells was identified as a negative regulator of “in-cell killing” via inhibiting CIC formation. CD44 functions to antagonize NK cell internalization by reducing N-cadherin-mediated intercellular adhesion and by enhancing Rho GTPase-regulated cellular stiffness as well. Remarkably, antibody-mediated blockade of CD44 signaling potentiated the suppressive effects of NK cells on tumor growth associated with increased heterotypic CIC formation. Together, we identified CIC-mediated “in-cell killing” as a promising strategy for cancer immunotherapy.
Collapse
Affiliation(s)
- Yan Su
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.,CAS Key Laboratory of Mechanical Behavior and Design of Materials, Department of Modern Mechanics, University of Science and Technology of China, Hefei, China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Tianzhi Luo
- CAS Key Laboratory of Mechanical Behavior and Design of Materials, Department of Modern Mechanics, University of Science and Technology of China, Hefei, China
| | - You Zheng
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Jie Fan
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - He Ren
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.,Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Meng Tang
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.,Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Zubiao Niu
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Chenxi Wang
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Yuqi Wang
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Zhengrong Zhang
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Jianqing Liang
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Banzhan Ruan
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Lihua Gao
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Zhaolie Chen
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China
| | - Gerry Melino
- Departments of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.,DZNE German Center for Neurodegenerative Diseases, Bonn, Germany
| | - Xiaoning Wang
- National Research Center of Geriatrics Diseases, Chinese PLA General Hospital, Beijing, China.,School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China
| | - Qiang Sun
- Beijing Institute of Biotechnology, Research Unit of Cell Death Mechanism, 2021RU008, Chinese Academy of Medical Science, 20 Dongda Street, Beijing, China.
| |
Collapse
|
12
|
Yang Y, Fan P, Liu J, Xie W, Liu N, Niu Z, Li Q, Song J, Tian Q, Bao Y, Wang H, Feng D. Thinopyrum intermedium TiAP1 interacts with a chitin deacetylase from Blumeria graminis f. sp. tritici and increases the resistance to Bgt in wheat. Plant Biotechnol J 2022; 20:454-467. [PMID: 34651397 PMCID: PMC8882775 DOI: 10.1111/pbi.13728] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Revised: 09/26/2021] [Accepted: 10/02/2021] [Indexed: 06/13/2023]
Abstract
The biotrophic fungal pathogen Blumeria graminis f. sp. tritici (Bgt) is a crucial factor causing reduction in global wheat production. Wild wheat relatives, for example Thinopyrum intermedium, is one of the wild-used parents in wheat disease-resistant breeding. From T. intermedium line, we identified the aspartic protease gene, TiAP1, which is involved in resistance against Bgt. TiAP1 is a secreted protein that accumulates in large amounts at the infection sites of Bgt and extends to the intercellular space. Yeast two-hybrid, luciferase complementation imaging and bimolecular florescent complimentary analysis showed that TiAP1 interacted with the chitin deacetylase (BgtCDA1) of Bgt. The yeast expression, purification and in vitro test confirmed the chitin deacetylase activity of BgtCDA1. The bombardment and VIGS-mediated host-induced gene silencing showed that BgtCDA1 promotes the invasion of Bgt. Transcriptome analysis showed the cell wall xylan metabolism, lignin biosynthesis-related and defence genes involved in the signal transduction were up-regulated in the transgenic TiAP1 wheat induced by Bgt. The TiAP1 in wheat may inactivate the deacetylation function of BgtCDA1, cause chitin oligomers expose to wheat chitin receptor, then trigger the wheat immune response to inhibit the growth and penetration of Bgt, and thereby enhance the resistance of wheat to pathogens.
Collapse
Affiliation(s)
- Yanlin Yang
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Pan Fan
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Jingxia Liu
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Wenjun Xie
- Plant Defence Genetics LabDepartment of Plant and Environmental SciencesUniversity of CopenhagenFrederiksberg CDenmark
| | - Na Liu
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Zubiao Niu
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Quanquan Li
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Jing Song
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Qiuju Tian
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Yinguang Bao
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Honggang Wang
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| | - Deshun Feng
- State Key Laboratory of Crop BiologyShandong Key Laboratory of Crop BiologyCollege of AgronomyShandong Agricultural UniversityTai’anChina
| |
Collapse
|
13
|
Selvadurai PA, Wu R, Bianchi P, Niu Z, Michail S, Madonna C, Wiemer S. A Methodology for Reconstructing Source Properties of a Conical Piezoelectric Actuator Using Array-Based Methods. J Nondestr Eval 2022; 41:23. [PMID: 35221414 PMCID: PMC8860964 DOI: 10.1007/s10921-022-00853-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/20/2021] [Accepted: 02/06/2022] [Indexed: 06/14/2023]
Abstract
We investigated the force produced by a conical piezoelectric (PZT, lead zirconate titanate) transducer actuated by high voltage pulses (HVP) in contact with a steel transfer plate. Using elastic wave propagation theory in a semi-infinite plate, we aimed to quantify the magnitude and estimate the shape of the force-time function via the body waves produced in the transfer plate using the displacement field recorded on an array of 20 absolutely calibrated PZT receivers. We first calibrated the receiver array using glass capillary fracture. We proceeded to use a conical PZT transducer to actively produce a source at the origin, allowing us to study the displacement field produced on the now calibrated PZT receiver array. We studied two types of HVP: An impulsive and step source. The calibrated receiver array was used to estimate the general shape of the force-time functions for each type of HVP. From our hypothesized force-time functions we were able to estimate the peak force produced by the PZT actuator: The impulsive source generated a force of f peak = 2.90 ± 0.42 N and the step source generated f peak = 1.79 ± 0.30 N, respectively, for a peak applied voltage of 273 V. This translates to an applied force of ∼ 0.011 N/V and 0.007 N/V for the impulse and step force-time functions, respectively, which is similar to estimates found in the literature for other conical transducers in contact with metallic transfer media. This measurement was verified directly by independent measurements of the peak force f peak using a dynamic force transducer. We found that our methodology correctly estimated the magnitude of the force but is limited to transducers with incident angles θ < 53 ∘ . Beyond this angle, overestimates of the force were observed due to the lack of body wave energy produced by the source. These results allow us to quantitatively determine the forces produced by active PZT techniques using only the measurement of the displacement field captured on a calibrated conical PZT array. Quantitative understanding of active PZT sources additionally constrains the transfer functions approach, which is commonly used in the non-destructive testing of materials and in other fields, such as rock physics and laboratory seismology.
Collapse
Affiliation(s)
| | - R. Wu
- Engineering Geology, Department of Earth Sciences, ETH Zürich, Zürich, Switzerland
| | - P. Bianchi
- Swiss Seismological Service, ETH Zürich, Zürich, Switzerland
| | - Z. Niu
- Department of Earth Sciences, ETH Zürich, Zürich, Switzerland
| | - S. Michail
- Swiss Seismological Service, ETH Zürich, Zürich, Switzerland
| | - C. Madonna
- Structural Geology and Tectonics Group, Geological Institute, Department of Earth Sciences, ETH Zürich, Zürich, Switzerland
| | - S. Wiemer
- Swiss Seismological Service, ETH Zürich, Zürich, Switzerland
| |
Collapse
|
14
|
Zhou L, Niu Z, Wang Y, Zheng Y, Zhu Y, Wang C, Gao X, Gao L, Zhang W, Zhang K, Melino G, Huang H, Wang X, Sun Q. Senescence as a dictator of patient outcomes and therapeutic efficacies in human gastric cancer. Cell Death Dis 2022; 8:13. [PMID: 35013121 PMCID: PMC8748965 DOI: 10.1038/s41420-021-00769-6] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2021] [Revised: 11/11/2021] [Accepted: 11/22/2021] [Indexed: 12/13/2022]
Abstract
Senescence is believed to be a pivotal player in the onset and progression of tumors as well as cancer therapy. However, the guiding roles of senescence in clinical outcomes and therapy selection for patients with cancer remain obscure, largely due to the absence of a feasible senescence signature. Here, by integrative analysis of single cell and bulk transcriptome data from multiple datasets of gastric cancer patients, we uncovered senescence as a veiled tumor feature characterized by senescence gene signature enriched, unexpectedly, in the noncancerous cells, and further identified two distinct senescence-associated subtypes based on the unsupervised clustering. Patients with the senescence subtype had higher tumor mutation loads and better prognosis as compared with the aggressive subtype. By the machine learning, we constructed a scoring system termed as senescore based on six signature genes: ADH1B, IL1A, SERPINE1, SPARC, EZH2, and TNFAIP2. Higher senescore demonstrated robustly predictive capability for longer overall and recurrence-free survival in 2290 gastric cancer samples, which was independently validated by the multiplex staining analysis of gastric cancer samples on the tissue microarray. Remarkably, the senescore signature served as a reliable predictor of chemotherapeutic and immunotherapeutic efficacies, with high-senescore patients benefited from immunotherapy, while low-senescore patients were responsive to chemotherapy. Collectively, we report senescence as a heretofore unrecognized hallmark of gastric cancer that impacts patient outcomes and therapeutic efficacy.
Collapse
Affiliation(s)
- Lulin Zhou
- School of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, China.,Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 20 Dongda Street, Beijing, 100071, China
| | - Zubiao Niu
- Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 20 Dongda Street, Beijing, 100071, China
| | - Yuqi Wang
- Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 20 Dongda Street, Beijing, 100071, China
| | - You Zheng
- Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 20 Dongda Street, Beijing, 100071, China
| | - Yichao Zhu
- Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 20 Dongda Street, Beijing, 100071, China
| | - Chenxi Wang
- Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 20 Dongda Street, Beijing, 100071, China
| | - Xiaoyan Gao
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing, 100038, China
| | - Lihua Gao
- Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 20 Dongda Street, Beijing, 100071, China
| | - Wen Zhang
- Department of Immunology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Kaitai Zhang
- State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - Gerry Melino
- Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", Rome, 00133, Italy.,DZNE German Center for Neurodegenerative Diseases, 53127, Bonn, Germany
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing, 100038, China.
| | - Xiaoning Wang
- School of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, China. .,Institute of Geriatrics, The second Medical Center, Beijing Key Laboratory of Aging and Geriatrics, National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, 100853, China. .,School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, China.
| | - Qiang Sun
- Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 20 Dongda Street, Beijing, 100071, China.
| |
Collapse
|
15
|
Heckman CJ, Riley M, Niu Z, Lu SE, Valdes-Rodriguez R, Yosipovitch G. A single-arm pilot of a web-based intervention to improve itch-related quality of life. J Eur Acad Dermatol Venereol 2021; 36:108-112. [PMID: 34549834 DOI: 10.1111/jdv.17686] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Accepted: 09/02/2021] [Indexed: 11/28/2022]
Abstract
BACKGROUND Many patients with chronic itch and atopic dermatitis (AD) or psoriasis do not receive/use available medical and psychosocial treatments properly due to system, provider and/or patient factors. OBJECTIVE An educational website (ITCH-RELIEF) to improve itch-related quality of life (QoL) for adults with AD or psoriasis and chronic itch was developed and assessed. ITCH RELIEF stands for Interactive Toolbox of Comprehensive Health Resources to Enhance Living with Itch - Educational Facilitation (for Adults). METHODS Single-arm pre- and post-test design with 1-month follow-up (N = 137 at baseline). RESULTS There was statistically and clinically significant improvement in the primary outcome of itch-related QoL impairment as assessed by the ItchyQoL from baseline [M = 78.9, 95% confidence interval (CI) = 75.9, 81.9] to follow up (M = 75.4, CI = 72.4, 78.5), P = 0.007, as well as statistically significant improvement in several itch-related secondary outcomes (all Ps < 0.05). CONCLUSIONS This study demonstrated initial effectiveness of an online intervention to improve itch-related QoL among individuals with AD or psoriasis and chronic itch. Future studies should address limitations by randomizing more heterogeneous participants, utilizing a longer follow-up and assessing medication use.
Collapse
Affiliation(s)
- C J Heckman
- Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
| | - M Riley
- Metronic Inc., Denver, CO, USA
| | - Z Niu
- Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
| | - S-E Lu
- Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA
| | - R Valdes-Rodriguez
- Department of Dermatology, University of Arkansas Medical Center, Little Rock, AR, USA
| | - G Yosipovitch
- Dr. Phillip Frost Department of Dermatology and Miami Itch Center, University of Miami, Miami, FL, USA
| |
Collapse
|
16
|
Niu Z, He M, Sun Q. Molecular mechanisms underlying cell-in-cell formation: core machineries and beyond. J Mol Cell Biol 2021; 13:329-334. [PMID: 33693765 PMCID: PMC8373266 DOI: 10.1093/jmcb/mjab015] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Revised: 01/06/2021] [Accepted: 01/12/2021] [Indexed: 12/28/2022] Open
Affiliation(s)
- Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing 100071, China
| | - Meifang He
- Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing 100071, China
- Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing 100071, China
| |
Collapse
|
17
|
Niu Z, Zhang Z, Gao X, Du P, Lu J, Yan B, Wang C, Zheng Y, Huang H, Sun Q. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal Transduct Target Ther 2021; 6:284. [PMID: 34315847 PMCID: PMC8313414 DOI: 10.1038/s41392-021-00704-2] [Citation(s) in RCA: 51] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Revised: 06/24/2021] [Accepted: 07/10/2021] [Indexed: 01/05/2023] Open
Affiliation(s)
- Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing, China
| | - Zhengrong Zhang
- Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing, China
| | - Xiaoyan Gao
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Peng Du
- Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing, China
| | - Jingjing Lu
- Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing, China
| | - Bohua Yan
- Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing, China
| | - Chenxi Wang
- Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing, China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China.
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology; Research Unit of Cell Death Mechanism, Chinese Academy of Medical Sciences, 2020RU009, Beijing, China.
| |
Collapse
|
18
|
Wang C, Zheng Y, Niu Z, Jiang X, Sun Q. The virological impacts of SARS-CoV-2 D614G mutation. J Mol Cell Biol 2021; 13:712-720. [PMID: 34289053 PMCID: PMC8344946 DOI: 10.1093/jmcb/mjab045] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Revised: 05/18/2021] [Accepted: 05/26/2021] [Indexed: 11/12/2022] Open
Abstract
The coronavirus diseases 2019 (COVID-19) caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 has caused more than 140 million infections worldwide by the end of April 2021. As an enveloped single-stranded positive-sense RNA virus, SARS-CoV-2 underwent constant evolution that produced novel variants carrying mutation conferring fitness advantages. The current prevalent D614G variant, with glycine substituted for aspartic acid at position 614 in the spike glycoprotein, is one of such variants that became the main circulating strain worldwide in a short period of time. Over the past year, intensive studies from all over the world had defined the epidemiological characteristics of this highly contagious variant and revealed the underlying mechanisms. This review aims at presenting an overall picture of the impacts of D614G mutation on virus transmission, elucidating the underlying mechanisms of D614G in virus pathogenicity, and providing insights into the development of effective therapeutics.
Collapse
Affiliation(s)
- Chenxi Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2020RU009, Beijing 100071, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2020RU009, Beijing 100071, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2020RU009, Beijing 100071, China
| | - Xiaoyi Jiang
- Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2020RU009, Beijing 100071, China
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, Research Unit of Cell Death Mechanism, Chinese Academy of Medical Science, 2020RU009, Beijing 100071, China
| |
Collapse
|
19
|
Xie B, Alismail S, Masood S, Lei X, Le M, Niu Z, Cordola Hsu AR, Li Y, Hwang W. Psychosocial adjustment mediates impacts of playmate positive support on body mass index and overweight risk in adolescents. Public Health 2021; 196:223-228. [PMID: 34280750 DOI: 10.1016/j.puhe.2021.05.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2020] [Revised: 05/19/2021] [Accepted: 05/28/2021] [Indexed: 10/20/2022]
Abstract
OBJECTIVES We examined the mediation effects of psychosocial adjustment on the impact of playmate positive support throughout childhood and early adolescence (from age 54 months to 11 years) on later body mass index (BMI) and overweight risk in middle adolescence (age 15 years). STUDY DESIGN This was a prospective cohort study. METHODS Among 844 children and their families, positive support between child-playmate dyads was repeatedly assessed from child's age 54 months to Grade 5. Long-term positive support between child-playmate dyads throughout childhood and early adolescence was prospectively linked to child's BMI and overweight/obesity status at age 15 years. The average scores of repeated assessments of internalizing and externalizing behavior problems from Grades 3 to 6 were used as mediators. RESULTS Significant mediations of internalizing and externalizing behavior problems were observed on pathways from positive support between child-playmate dyads to later BMI and overweight/obesity status at age 15 years. The observed mediations were mainly sustained with pronounced magnitudes in girls, but not in boys. CONCLUSIONS Our findings demonstrated a significant mediating role of psychosocial adjustment. Future research efforts are highly encouraged to replicate our findings and further explore this underlying mediation mechanism.
Collapse
Affiliation(s)
- B Xie
- School of Community and Global Health, Claremont Graduate University, Claremont, CA, 91711, USA.
| | - S Alismail
- School of Community and Global Health, Claremont Graduate University, Claremont, CA, 91711, USA
| | - S Masood
- School of Community and Global Health, Claremont Graduate University, Claremont, CA, 91711, USA; School of Medicine, California University of Science and Medicine, San Bernardino, CA, 92408, USA
| | - X Lei
- School of Community and Global Health, Claremont Graduate University, Claremont, CA, 91711, USA; Department of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA
| | - M Le
- School of Community and Global Health, Claremont Graduate University, Claremont, CA, 91711, USA
| | - Z Niu
- Department of Epidemiology and Environmental Health, University at Buffalo, State University of New York, Buffalo, NY, 14260
| | - A R Cordola Hsu
- School of Community and Global Health, Claremont Graduate University, Claremont, CA, 91711, USA; Heart Disease Prevention Program, Division of Cardiology, Department of Medicine, University of California at Irvine School of Medicine, Irvine, CA, 92617, USA
| | - Y Li
- School of Social Work, San Diego State University, San Diego, CA, 92182, USA
| | - W Hwang
- Department of Psychological Science, Claremont McKenna College, Claremont, CA, 91711, USA
| |
Collapse
|
20
|
Wang Y, Niu Z, Zhou L, Zhou Y, Ma Q, Zhu Y, Liu M, Shi Y, Tai Y, Shao Q, Ge J, Hua J, Gao L, Huang H, Jiang H, Sun Q. Subtype-Based Analysis of Cell-in-Cell Structures in Esophageal Squamous Cell Carcinoma. Front Oncol 2021; 11:670051. [PMID: 34178655 PMCID: PMC8231019 DOI: 10.3389/fonc.2021.670051] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2021] [Accepted: 05/19/2021] [Indexed: 11/29/2022] Open
Abstract
Cell-in-cell (CIC) structures are defined as the special structures with one or more cells enclosed inside another one. Increasing data indicated that CIC structures were functional surrogates of complicated cell behaviors and prognosis predictor in heterogeneous cancers. However, the CIC structure profiling and its prognostic value have not been reported in human esophageal squamous cell Carcinoma (ESCC). We conducted the analysis of subtyped CIC-based profiling in ESCC using "epithelium-macrophage-leukocyte" (EML) multiplex staining and examined the prognostic value of CIC structure profiling through Kaplan-Meier plotting and Cox regression model. Totally, five CIC structure subtypes were identified in ESCC tissue and the majority of them was homotypic CIC (hoCIC) with tumor cells inside tumor cells (TiT). By univariate and multivariate analyses, TiT was shown to be an independent prognostic factor for resectable ESCC, and patients with higher density of TiT tended to have longer post-operational survival time. Furthermore, in subpopulation analysis stratified by TNM stage, high TiT density was associated with longer overall survival (OS) in patients of TNM stages III and IV as compared with patients with low TiT density (mean OS: 51 vs 15 months, P = 0.04) and T3 stage (mean OS: 57 vs 17 months, P=0.024). Together, we reported the first CIC structure profiling in ESCC and explored the prognostic value of subtyped CIC structures, which supported the notion that functional pathology with CIC structure profiling is an emerging prognostic factor for human cancers, such as ESCC.
Collapse
Affiliation(s)
- Yuqi Wang
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China
- Research Unit of Cell Death Mechanism, Institute of Biotechnology, Chinese Academy of Medical Science, Beijing, China
| | - Zubiao Niu
- Research Unit of Cell Death Mechanism, Institute of Biotechnology, Chinese Academy of Medical Science, Beijing, China
| | - Lulin Zhou
- Research Unit of Cell Death Mechanism, Institute of Biotechnology, Chinese Academy of Medical Science, Beijing, China
- School of Medicine, Nankai University, Tianjin, China
| | - Yongan Zhou
- Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Military Medical University, Xi’an, China
| | - Qunfeng Ma
- Department of Thoracic Surgery, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Yichao Zhu
- Research Unit of Cell Death Mechanism, Institute of Biotechnology, Chinese Academy of Medical Science, Beijing, China
| | - Mengzhe Liu
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China
| | - Yinan Shi
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China
- Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China
| | - Yanhong Tai
- Department of Pathology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
| | - Qiuju Shao
- Department of Radiotherapy, The Second Affiliated Hospital of Air Force Military Medical University, Xi’an, China
| | - Jianlin Ge
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China
| | - Jilei Hua
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China
| | - Lihua Gao
- Research Unit of Cell Death Mechanism, Institute of Biotechnology, Chinese Academy of Medical Science, Beijing, China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Hong Jiang
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China
| | - Qiang Sun
- Research Unit of Cell Death Mechanism, Institute of Biotechnology, Chinese Academy of Medical Science, Beijing, China
| |
Collapse
|
21
|
Wang M, Niu Z, Qin H, Ruan B, Zheng Y, Ning X, Gu S, Gao L, Chen Z, Wang X, Huang H, Ma L, Sun Q. Mechanical Ring Interfaces between Adherens Junction and Contractile Actomyosin to Coordinate Entotic Cell-in-Cell Formation. Cell Rep 2021; 32:108071. [PMID: 32846129 DOI: 10.1016/j.celrep.2020.108071] [Citation(s) in RCA: 28] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2019] [Revised: 01/21/2020] [Accepted: 08/03/2020] [Indexed: 12/15/2022] Open
Abstract
Entosis is a cell-in-cell (CIC)-mediated death program. Contractile actomyosin (CA) and the adherens junction (AJ) are two core elements essential for entotic CIC formation, but the molecular structures interfacing them remain poorly understood. Here, we report the characterization of a ring-like structure interfacing between the peripheries of invading and engulfing cells. The ring-like structure is a multi-molecular complex consisting of adhesive and cytoskeletal proteins, in which the mechanical sensor vinculin is highly enriched. The vinculin-enriched structure senses mechanical force imposed on cells, as indicated by fluorescence resonance energy transfer (FRET) analysis, and is thus termed the mechanical ring (MR). The MR actively interacts with CA and the AJ to help establish and maintain polarized actomyosin that drives cell internalization. Vinculin depletion leads to compromised MR formation, CA depolarization, and subsequent CIC failure. In summary, we suggest that the vinculin-enriched MR, in addition to CA and AJ, is another core element essential for entosis.
Collapse
Affiliation(s)
- Manna Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China; Institute of Molecular Immunology, Southern Medical University, Guangzhou 510515, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China
| | - Hongquan Qin
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China; Institute of Molecular Immunology, Southern Medical University, Guangzhou 510515, China
| | - Banzhan Ruan
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China
| | - Xiangkai Ning
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China
| | - Songzhi Gu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China
| | - Lihua Gao
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China
| | - Zhaolie Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China
| | - Xiaoning Wang
- National Clinic Center of Geriatric, the Chinese PLA General Hospital, Beijing 100853, China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
| | - Li Ma
- Institute of Molecular Immunology, Southern Medical University, Guangzhou 510515, China.
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, China.
| |
Collapse
|
22
|
Liang J, Niu Z, Zhang B, Yu X, Zheng Y, Wang C, Ren H, Wang M, Ruan B, Qin H, Zhang X, Gu S, Sai X, Tai Y, Gao L, Ma L, Chen Z, Huang H, Wang X, Sun Q. p53-dependent elimination of aneuploid mitotic offspring by entosis. Cell Death Differ 2021; 28:799-813. [PMID: 33110215 PMCID: PMC7862607 DOI: 10.1038/s41418-020-00645-3] [Citation(s) in RCA: 33] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2020] [Accepted: 10/12/2020] [Indexed: 12/31/2022] Open
Abstract
Entosis was proposed to promote aneuploidy and genome instability by cell-in-cell mediated engulfment in tumor cells. We reported here, in epithelial cells, that entosis coupled with mitotic arrest functions to counteract genome instability by targeting aneuploid mitotic progenies for engulfment and elimination. We found that the formation of cell-in-cell structures associated with prolonged mitosis, which was sufficient to induce entosis. This process was controlled by the tumor suppressor p53 (wild-type) that upregulates Rnd3 expression in response to DNA damages associated with prolonged metaphase. Rnd3-compartmentalized RhoA activities accumulated during prolonged metaphase to drive cell-in-cell formation. Remarkably, this prolonged mitosis-induced entosis selectively targets non-diploid progenies for internalization, blockade of which increased aneuploidy. Thus, our work uncovered a heretofore unrecognized mechanism of mitotic surveillance for entosis, which eliminates newly born abnormal daughter cells in a p53-dependent way, implicating in the maintenance of genome integrity.
Collapse
Affiliation(s)
- Jianqing Liang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
- State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, 2005 Songhu Road, Shanghai, 200438, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - Bo Zhang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing, 100038, China
| | - Xiaochen Yu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - Chenxi Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - He Ren
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing, 100038, China
| | - Manna Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
- Institute of Molecular Immunology, Southern Medical University, Guangzhou, 510515, China
| | - Banzhan Ruan
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - Hongquan Qin
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
- Institute of Molecular Immunology, Southern Medical University, Guangzhou, 510515, China
| | - Xin Zhang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
- Department of Pediatric Hematology and Oncology, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China
| | - Songzhi Gu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - Xiaoyong Sai
- National Clinic Center of Geriatric & the State Key Laboratory of Kidney, the Chinese PLA General Hospital, Beijing, 100853, China
| | - Yanhong Tai
- The 307 Hospital, 8 Dongda Street, Beijing, 100071, China
| | - Lihua Gao
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - Li Ma
- Institute of Molecular Immunology, Southern Medical University, Guangzhou, 510515, China
| | - Zhaolie Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing, 100038, China.
| | - Xiaoning Wang
- National Clinic Center of Geriatric & the State Key Laboratory of Kidney, the Chinese PLA General Hospital, Beijing, 100853, China.
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
| |
Collapse
|
23
|
Su Y, Ren H, Tang M, Zheng Y, Zhang B, Wang C, Hou X, Niu Z, Wang Z, Gao X, Gao L, Jiang H, Chen Z, Luo T, Sun Q. Role and dynamics of vacuolar pH during cell-in-cell mediated death. Cell Death Dis 2021; 12:119. [PMID: 33483474 PMCID: PMC7822940 DOI: 10.1038/s41419-021-03396-2] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2020] [Revised: 12/14/2020] [Accepted: 12/16/2020] [Indexed: 02/07/2023]
Abstract
The nonautonomous cell death by entosis was mediated by the so-called cell-in-cell structures, which were believed to kill the internalized cells by a mechanism dependent on acidified lysosomes. However, the precise values and roles of pH critical for the death of the internalized cells remained undetermined yet. We creatively employed keima, a fluorescent protein that displays different excitation spectra in responding to pH changes, to monitor the pH dynamics of the entotic vacuoles during cell-in-cell mediated death. We found that different cells varied in their basal intracellular pH, and the pH was relatively stable for entotic vacuoles containing live cells, but sharply dropped to a narrow range along with the inner cell death. In contrast, the lipidation of entotic vacuoles by LC3 displayed previously underappreciated complex patterns associated with entotic and apoptotic death, respectively. The pH decline seemed to play distinct roles in the two types of inner cell deaths, where apoptosis is preceded with moderate pH decline while a profound pH decline is likely to be determinate for entotic death. Whereas the cancer cells seemed to be lesser tolerant to acidified environments than noncancerous cells, manipulating vacuolar pH could effectively control inner cell fates and switch the ways whereby inner cell die. Together, this study demonstrated for the first time the pH dynamics of entotic vacuoles that dictate the fates of internalized cells, providing a rationale for tuning cellular pH as a potential way to treat cell-in-cell associated diseases such as cancer.
Collapse
Affiliation(s)
- Yan Su
- CAS Key Laboratory of Mechanical Behavior and Design of Materials, Department of Modern Mechanics, University of Science and Technology of China, Hefei, China
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - He Ren
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Meng Tang
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Bo Zhang
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Chenxi Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Xinyu Hou
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Zhongyi Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Xiaoyan Gao
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Lihua Gao
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Hong Jiang
- College of Life Science and Bioengineering, School of Science, Beijing Jiaotong University, Beijing, China
| | - Zhaolie Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Tianzhi Luo
- CAS Key Laboratory of Mechanical Behavior and Design of Materials, Department of Modern Mechanics, University of Science and Technology of China, Hefei, China.
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China.
- Research Unit of Cell Death Mechanism, 2020RU009, Chinese Academy of Medical Science, Beijing, China.
| |
Collapse
|
24
|
Pan Q, Zheng H, Zhu W, Niu Z, Li H, Fang Y, Zheng Y, Li D, Lou H, Hu H, Zhai C, Wang W, Lou F, Jin W, Wang X, Han W, Pan H. Body composition alteration and inflammation are independent predictors of survival in lung cancer patients treated with anlotinib. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
25
|
Zhou L, Niu Z, Jiang X, Zhang Z, Zheng Y, Wang Z, Zhu Y, Gao L, Huang H, Wang X, Sun Q. SARS-CoV-2 Targets by the pscRNA Profiling of ACE2, TMPRSS2 and Furin Proteases. iScience 2020; 23:101744. [PMID: 33134888 PMCID: PMC7591870 DOI: 10.1016/j.isci.2020.101744] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2020] [Revised: 07/15/2020] [Accepted: 10/26/2020] [Indexed: 02/07/2023] Open
Abstract
The cellular targets of SARS-CoV-2, the novel coronavirus causing the COVID-19 pandemic, is still rudimentary. Here, we incorporated the protein information to analyze the expression of ACE2, the SARS-CoV-2 receptor, together with co-factors, TMPRSS2 and Furin, at single-cell level in situ, which we called protein-proofed single-cell RNA (pscRNA) profiling. Systemic analysis across 36 tissues revealed a rank list of candidate cells potentially vulnerable to SARS-CoV-2. The top targets are lung AT2 cells and macrophages, then cardiomyocytes and adrenal gland stromal cells, followed by stromal cells in testis, ovary, and thyroid, whereas the kidney proximal tubule cells, cholangiocytes, and enterocytes are less likely to be the primary SARS-CoV-2 targets. Actually, the stomach may constitute a physical barrier against SARS-CoV-2 as the acidic environment (pH < 2.0) could completely inactivate SARS-CoV-2 pseudo-viruses. Together, we provide a comprehensive view on the potential SARS-CoV-2 targets by pscRNA profiling.
Collapse
Affiliation(s)
- Lulin Zhou
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
- School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, P. R. China
| | - Zubiao Niu
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
| | - Xiaoyi Jiang
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing 100038, P. R. China
| | - Zhengrong Zhang
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
| | - You Zheng
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
| | - Zhongyi Wang
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
| | - Yichao Zhu
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
| | - Lihua Gao
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing 100038, P. R. China
| | - Xiaoning Wang
- School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, P. R. China
- School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, P. R. China
- National Clinic Center of Geriatric, the Chinese PLA General Hospital, Beijing 100853, P. R. China
| | - Qiang Sun
- Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R. China
| |
Collapse
|
26
|
Li S, Zhou L, Chen R, Chen Y, Niu Z, Qian L, Fang Y, Xu L, Xu H, Zhang L. Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma. Clin Radiol 2020; 76:161.e1-161.e10. [PMID: 33198943 DOI: 10.1016/j.crad.2020.10.009] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Accepted: 10/08/2020] [Indexed: 12/12/2022]
Abstract
AIM To investigate the diagnostic efficacy of the contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma (HCC) compared with magnetic resonance imaging (MRI) LI-RADS. MATERIALS AND METHODS CEUS and MRI data were analysed retrospectively according to the LI-RADS scheme. Follow-up results and pathological findings served as the reference standard. Receiver operating characteristic (ROC) curve analysis was used to reveal the area under the curve (AUC). The sensitivity, specificity, accuracy, and positive (PPV) and negative predictive values (NPV) of LR-5 for determining HCC were calculated. The intra-observer agreement of CEUS LI-RADS was also evaluated. RESULTS Eighty-four patients with 86 liver observations were enrolled. Forty-two observations were classified as LR-5 by CEUS and MRI, respectively. Based on the reference standard, 53 nodules were HCC. The AUCs were 0.876 for CEUS and 0.873 for MRI, without a significant difference (Z=0.050, p=0.960). The sensitivity, specificity, PPV, NPV, and accuracy of LR-5 was 75.47%, 93.94%, 95.24%, 70.45%, 82.56% with CEUS and 73.58%, 90.9%, 92.86%, 68.18%, 80.23% with MRI, respectively. There was a significant difference in specificity between CEUS and MRI (p=0.006). There was almost perfect agreement for arterial phase hyperenhancement (k=0.870), substantial agreement for washout (k=0.765) and CEUS LI-RADS category (k=0.787). CONCLUSION The CEUS LI-RADS scheme is an effective diagnostic tool for HCC with substantial intra-observer reliability. The diagnostic performance of CEUS LI-RADS for determining HCC was comparable to MRI LI-RADS, and the specificity of CEUS LR-5 was significantly higher.
Collapse
Affiliation(s)
- S Li
- Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - L Zhou
- Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - R Chen
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - Y Chen
- Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - Z Niu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - L Qian
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - Y Fang
- Department of Oncology, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - L Xu
- Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - H Xu
- Department of Ultrasound, Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou, China
| | - L Zhang
- Department of Ultrasound, Affiliated Hangzhou First People's Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
| |
Collapse
|
27
|
Lim H, Kim Y, Huang YH, Shao G, Kim D, Cho S, Hsu CH, Lin SM, Jeng LB, Kuo KK, Mao Y, Zhu K, Hong Y, Lee H, Ryoo BY, Niu Z, Wu L, Fiala-Buskies S, Kapur S, Qin S. 173P Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Interim results from the observational REFINE study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
28
|
Huang H, He M, Zhang Y, Zhang B, Niu Z, Zheng Y, Li W, Cui P, Wang X, Sun Q. Identification and validation of heterotypic cell-in-cell structure as an adverse prognostic predictor for young patients of resectable pancreatic ductal adenocarcinoma. Signal Transduct Target Ther 2020; 5:246. [PMID: 33082315 PMCID: PMC7576137 DOI: 10.1038/s41392-020-00346-w] [Citation(s) in RCA: 22] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2020] [Revised: 09/07/2020] [Accepted: 09/21/2020] [Indexed: 11/15/2022] Open
Affiliation(s)
- Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 Tieyi Road, Beijing, 100038, China.
| | - Meifang He
- Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, China
| | - Yanbin Zhang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 Tieyi Road, Beijing, 100038, China
| | - Bo Zhang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 Tieyi Road, Beijing, 100038, China.,Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China
| | - Wen Li
- Laboratory of General Surgery, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, China
| | - Peilin Cui
- Department of Gastroenterology, Beijing Tiantan Hospital of Capital Medical University, Beijing, 100070, China.
| | - Xiaoning Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing, 100071, China.
| |
Collapse
|
29
|
Lim H, Kim Y, Huang YH, Shao G, Kim D, Cho S, Hsu CH, Lin SM, Jeng LB, Kuo KK, Mao Y, Zhu K, Hong Y, Lee H, Ryoo BY, Niu Z, Wu L, Fiala-Buskies S, Kapur S, Qin S. 1009P Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Interim results from the observational REFINE study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1125] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
30
|
Wang C, Chen A, Ruan B, Niu Z, Su Y, Qin H, Zheng Y, Zhang B, Gao L, Chen Z, Huang H, Wang X, Sun Q. PCDH7 Inhibits the Formation of Homotypic Cell-in-Cell Structure. Front Cell Dev Biol 2020; 8:329. [PMID: 32457908 PMCID: PMC7225324 DOI: 10.3389/fcell.2020.00329] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2020] [Accepted: 04/16/2020] [Indexed: 12/13/2022] Open
Abstract
Though homotypic cell-in-cell (hoCIC) structures are implicated in the development and progression of multiple human tumors, the molecular mechanisms underlying their formation remain poorly understood. We found that the expression of Protocadherin-7 (PCDH7), an integral membrane protein, was negatively associated with the formation of hoCIC structures. Overexpression of PCDH7 efficiently inhibits, while its depletion significantly enhances, hoCIC formation, which was attributed to its regulation on intercellular adhesion and contractile actomyosin as well. Via directly interacting with and inactivating PP1α, a protein phosphatase that dephosphorylates pMLC2, PCDH7 increases the level of pMLC2 leading to enhanced actomyosin at the intercellular region and compromised hoCIC formation. Remarkably, PCDH7 enhanced anchorage-independent cell growth in a hoCIC-dependent manner. Together, we identified PCDH7 as the first trans-membrane protein that inhibits hoCIC formation to promote tumor growth.
Collapse
Affiliation(s)
- Chenxi Wang
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.,Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Ang Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Banzhan Ruan
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China.,Department of Biology, Hainan Medical University, Haikou, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Yan Su
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Hongquan Qin
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Bo Zhang
- Department of Oncology, Capital Medical University, Beijing, China
| | - Lihua Gao
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Zhaolie Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Hongyan Huang
- Department of Oncology, Capital Medical University, Beijing, China
| | - Xiaoning Wang
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China.,Beijing Key Laboratory of Aging and Geriatrics, Chinese PLA General Hospital, Beijing, China
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| |
Collapse
|
31
|
Ruan B, Niu Z, Jiang X, Li Z, Tai Y, Huang H, Sun Q. High Frequency of Cell-in-Cell Formation in Heterogeneous Human Breast Cancer Tissue in a Patient With Poor Prognosis: A Case Report and Literature Review. Front Oncol 2019; 9:1444. [PMID: 31921689 PMCID: PMC6930920 DOI: 10.3389/fonc.2019.01444] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Accepted: 12/03/2019] [Indexed: 01/20/2023] Open
Abstract
Cell cannibalism is a unique pathological phenomenon that has been observed at low frequency in a variety of human tumor samples (<0.5%), including breast cancer. Cannibalistic cells typically form cell-in-cell (CIC) structures characterized by enclosure of one cell or more by another, mediating a novel type of cell death "entosis," which was proposed as the type IV cell death. A large number of CIC structures are generally associated with malignant transformation and progression, and they are believed to be primed by and form among heterogeneous cells. However, there is currently no in vivo evidence from human tumor samples. In this case report, covering a 37-year-old female breast cancer patient, we observed considerable heterogeneity and proliferative activity (>70% Ki-67 positivity) in her breast cancer cells, accompanied by high frequency of CIC formation (~6%) and poor prognosis. We consider this a typical example of cell cannibalism, supporting a role of heterogeneity in cell-in-cell formation and malignant progression. It may serve as a pretest basis for further investigations of cell-in-cell biology and breast cancer treatment.
Collapse
Affiliation(s)
- Banzhan Ruan
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
- Department of Biology, Hainan Medical University, Haikou, China
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Xiaoyi Jiang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Zhuo Li
- The Fifth Medical Center of the Chinese PLA General Hospital, Beijing, China
| | - Yanhong Tai
- The Fifth Medical Center of the Chinese PLA General Hospital, Beijing, China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| |
Collapse
|
32
|
Cao J, Guo W, Niu Z, Wang Z, Hu W, Ma X, Liu D, Shi J, Yao M. Genomic profiling in Chinese biliary tract cancer patients with PI3K/AKT/mTOR pathway and RAS gene mutations. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz247.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
33
|
Niu Z, Wei Y, Feng Q, Zhu D, Xu J. Robot-assisted natural orifice specimen extraction surgery for radical resection of colorectal cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz246.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Nicolau S, Niu Z, Ling K, Milone M. P.21Genetic analysis of first-degree relatives with inclusion body myositis. Neuromuscul Disord 2019. [DOI: 10.1016/j.nmd.2019.06.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
35
|
Zhang X, Niu Z, Qin H, Fan J, Wang M, Zhang B, Zheng Y, Gao L, Chen Z, Tai Y, Yang M, Huang H, Sun Q. Subtype-Based Prognostic Analysis of Cell-in-Cell Structures in Early Breast Cancer. Front Oncol 2019; 9:895. [PMID: 31681557 PMCID: PMC6798043 DOI: 10.3389/fonc.2019.00895] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2019] [Accepted: 08/28/2019] [Indexed: 01/20/2023] Open
Abstract
Though current pathological methods are greatly improved, they provide rather limited functional information. Cell-in-cell structures (CICs), arising from active cell–cell interaction, are functional surrogates of complicated cell behaviors within heterogeneous cancers. In light of this, we performed the subtype-based CIC profiling in human breast cancers by the “EML” multiplex staining method, and accessed their values as prognostic factors by Cox univariate, multivariate, and nomogram analysis. CICs were detected in cancer specimens but not in normal breast tissues. A total of five types of CICs were identified with one homotypic subtype (91%) and four heterotypic subtypes (9%). Overall CICs (oCICs) significantly associated with patient overall survival (OS) (P = 0.011) as an independent protective factor (HR = 0.423, 95% CI, 0.227–0.785; P = 0.006). Remarkably, three CICs subtypes (TiT, TiM, and MiT) were also independent prognostic factors. Among them, higher TiT, from homotypic cannibalism between tumor cells, predicted longer patient survival (HR = 0.529, 95% CI, 0.288–0.973; P = 0.04) in a way similar to that of oCICs and that (HR = 0.524, 95% CI, 0.286–0.962; P = 0.037) of heterotypic TiM (tumor cell inside macrophage); conversely, the presence of MiT (macrophage inside tumor cell) predicted a death hazard of 2.608 (95% CI, 1.344–5.063; P = 0.05). Moreover, each CIC subtype tended to preferentially affect different categories of breast cancer, with TiT (P < 0.0001) and oCICs (P = 0.008) targeting luminal B (Her2+), TiM (P = 0.011) targeting HR− (Her2+/HR− and TNBC), and MiT targeting luminal A (P = 0.017) and luminal B (Her−) (P = 0.006). Furthermore, nomogram analysis suggested that CICs impacted patient outcomes in contributions comparable (for oCICs, TiT, and TiM), or even superior (for MiT), to TNM stage and breast cancer subtype, and incorporating CICs improved nomogram performance. Together, we propose CICs profiling as a valuable way for prognostic analysis of breast cancer and that CICs and their subtypes, such as MiT, may serve as a type of novel functional markers assisting clinical practices.
Collapse
Affiliation(s)
- Xin Zhang
- Department of Pediatric, Nanfang Hospital, Southern Medical University, Guangzhou, China.,Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China.,The Seventh Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Hongquan Qin
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Jie Fan
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Manna Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Bo Zhang
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China.,Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Lihua Gao
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Zhaolie Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| | - Yanhong Tai
- Department of Pathology, The Fifth Medical Center, General Hospital of PLA, Beijing, China
| | - Mo Yang
- Department of Pediatric, Nanfang Hospital, Southern Medical University, Guangzhou, China.,The Seventh Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.,Lian Jiang People's Hospital, Lianjiang, China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing, China
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, Beijing, China
| |
Collapse
|
36
|
Liu CX, Niu Z, Zhang JM, Yang SL, Wang Y, Li CY, Zeng Q. [An analysis of medical X-ray examination frequency in ten hospitals in Tianjin, China]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2019; 36:830-833. [PMID: 30646646 DOI: 10.3760/cma.j.issn.1001-9391.2018.11.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the usage frequency of radiological diagnosis devices in ten hospitals in Tianjin, China, and to provide a basis for the survey of medical radiation frequency in Tianjin. Methods: Ten hospitals from the ten districts in Tianjin were enrolled as subjects by a convenient sampling method. A survey was conducted to assess the general information and radiological diagnosis device information and usage frequency in those hospitals in 2016. The radiological examination frequency in Tianjin was estimated. Results: A total of 610 458 patients received radiological examinations in the sampled hospitals in 2016. In those patients, 371 882 received X-ray examinations for imaging and 238 576 for computed tomography (CT) ; there were slightly more female patients than male patients, suggesting a relatively equal gender distribution; patients older than 40 years accounted for 65.53%, which was the highest among all the age groups. Different types of radiological diagnosis devices were mostly used in tertiary and secondary hospitals. In Tianjin, the estimated frequency of X-ray examination for imaging and CT scanning was 451 and 188 per thousand people, respectively, in 2016. Conclusion: The frequency of radiological diagnosis is relatively high in the ten hospitals in Tianjin. The investigation of medical radiation in Tianjin needs to be improved.
Collapse
Affiliation(s)
- C X Liu
- Department of Radiological Health, Tianjin Centers For Disease Control and Prevention, Tianjin 300011, China
| | | | | | | | | | | | | |
Collapse
|
37
|
Lu S, Xu F, Hu W, Niu Z, Cai H, Chen Y, Tu Q, Zhang Y, Chen W, Liu W, Tang S, Zhang Z. SCD1 methylation in subcutaneous adipose tissue associated with menopausal age. Climacteric 2019; 22:395-402. [PMID: 30777456 DOI: 10.1080/13697137.2019.1571028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- S. Lu
- Department of Obstetrics and Gynecology, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China
| | - F. Xu
- Department of Gastroenterology, Hangzhou Third People's Hospital, Hangzhou, China
| | - W. Hu
- Department of Obstetrics and Gynecology, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China
| | - Z. Niu
- Department of Obstetrics and Gynecology, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou, China
| | - H. Cai
- Department of Obstetrics and Gynecology, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou, China
| | - Y. Chen
- Laboratory of Gene Diagnosis, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou, China
| | - Q. Tu
- Laboratory of Gene Diagnosis, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou, China
| | - Y. Zhang
- Department of Obstetrics and Gynecology, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China
| | - W. Chen
- Department of Obstetrics and Gynecology, The Second People's Hospital of Tonglu, Hangzhou, China
| | - W. Liu
- Department of Obstetrics and Gynecology, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China
| | - S. Tang
- Department of Obstetrics and Gynecology, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China
| | - Z. Zhang
- Department of Obstetrics and Gynecology, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China
| |
Collapse
|
38
|
Ruan B, Wang C, Chen A, Liang J, Niu Z, Zheng Y, Fan J, Gao L, Huang H, Wang X, Sun Q. Expression profiling identified IL-8 as a regulator of homotypic cell-in-cell formation. BMB Rep 2018. [PMID: 30021676 PMCID: PMC6130832 DOI: 10.5483/bmbrep.2018.51.8.089] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Homotypic cell-in-cell (CIC) structures forming between cancer cells were proposed to promote tumor evolution via entosis, a nonapoptotic cell death process. However, the mechanisms underlying their formation remained poorly understood. We performed a microarray analysis to identify genes associated with homotypic CIC formation. Cancer cells differing in their ability to form homotypic CIC structures were selected for the study. Association analysis identified 73 probe sets for 62 candidate genes potentially involved in CIC formation. Among them, twenty-one genes were downregulated while 41 genes were upregulated. Pathway analysis identified a gene interaction network centered on IL-8, which was upregulated in high CIC cells. Remarkably, CIC formation was significantly inhibited by IL-8 knockdown and enhanced upon recombinant IL-8 treatment, which correlated with altered cell-cell adhesion and expression of adhesive molecules such as P-cadherin and γ-catenin. Together, our work identified IL-8 as a positive regulator of homotypic CIC formation via enhancing intercellular adhesion. [BMB Reports 2018; 51(8): 412-417].
Collapse
Affiliation(s)
- Banzhan Ruan
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, P.R.; Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R., China
| | - Chenxi Wang
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, P.R.; Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R., China
| | - Ang Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R., China
| | - Jianqing Liang
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, P.R.; Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R., China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R., China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R., China
| | - Jie Fan
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R.; 307 Hospital, Beijing 100071, P. R., China
| | - Lihua Gao
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R., China
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, Beijing 100038, P. R., China
| | - Xiaoning Wang
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, P.R.; The Key Laboratory of Normal aging & Geriatric, the Chinese PLA General Hospital, Beijing 100853, P.R., China
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, P.R.; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an 710032, P. R., China
| |
Collapse
|
39
|
Wang Y, Gu W, Zhang Y, Li K, Niu Z, Zheng Y, Cui Q, Wang A, Chen H, Shi W, Wang K, Yao M. Somatic and germline mutations of Chinese gastric cancer patients. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy269.165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Liang J, Fan J, Wang M, Niu Z, Zhang Z, Yuan L, Tai Y, Chen Z, Song S, Wang X, Liu X, Huang H, Sun Q. CDKN2A inhibits formation of homotypic cell-in-cell structures. Oncogenesis 2018; 7:50. [PMID: 29904067 PMCID: PMC6002405 DOI: 10.1038/s41389-018-0056-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2017] [Revised: 04/07/2018] [Accepted: 04/28/2018] [Indexed: 01/26/2023] Open
Abstract
Cell-in-cell (CIC) structures, characterized by enclosure of one or more cells within another cell, were extensively documented in human cancers. Although elevated CIC formation was found in cancers with CDKN2A inactivation, a causal link between them remains to be established. We reported here that inhibiting CDKN2A expression effectively promoted homotypic CIC formation, whereas ectopic overexpression of p16INK4a or p14ARF, two proteins encoded by CDKN2A gene, significantly suppressed CIC formation in MCF7 cells. The regulation of CIC formation by CDKN2A was tightly correlated with subcellular redistribution of E-cadherin, F-actin rearrangement and reduced phosphorylation of myosin light chain 2 (p-MLC2), consistent with which, CDKN2A expression imparted cells winner/outer identity in competition assay. Moreover, CIC formation negatively correlates with p16INK4a expression in human breast cancers. Thus, our work identifies CDKN2A as the first tumor suppressor whose inactivation promotes homotypic CIC formation in human cancer cells.
Collapse
Affiliation(s)
- Jianqing Liang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, 100038, Beijing, P. R. China.,Institute of Biotechnology, 20 Dongda Street, 100071, Beijing, P.R. China.,School of Biological Science and Engineering, South China University of Technology, 510000, Guangzhou, P.R. China
| | - Jie Fan
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, 100038, Beijing, P. R. China.,Institute of Biotechnology, 20 Dongda Street, 100071, Beijing, P.R. China.,The 307 Hospital, 8 Dongda Street, 100071, Beijing, P. R. China
| | - Manna Wang
- Institute of Biotechnology, 20 Dongda Street, 100071, Beijing, P.R. China
| | - Zubiao Niu
- Institute of Biotechnology, 20 Dongda Street, 100071, Beijing, P.R. China
| | - Zhengrong Zhang
- Institute of Biotechnology, 20 Dongda Street, 100071, Beijing, P.R. China
| | - Long Yuan
- Institute of Biotechnology, 20 Dongda Street, 100071, Beijing, P.R. China
| | - Yanhong Tai
- The 307 Hospital, 8 Dongda Street, 100071, Beijing, P. R. China
| | - Zhaolie Chen
- Institute of Biotechnology, 20 Dongda Street, 100071, Beijing, P.R. China
| | - Santai Song
- The 307 Hospital, 8 Dongda Street, 100071, Beijing, P. R. China
| | - Xiaoning Wang
- School of Biological Science and Engineering, South China University of Technology, 510000, Guangzhou, P.R. China
| | - Xiaoqing Liu
- The 307 Hospital, 8 Dongda Street, 100071, Beijing, P. R. China.
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, 100038, Beijing, P. R. China.
| | - Qiang Sun
- Institute of Biotechnology, 20 Dongda Street, 100071, Beijing, P.R. China.
| |
Collapse
|
41
|
Xu C, Tang X, Niu Z, Li Z. Studies of Adsorbents for Hemoperfusion in Artificial Liver Support. I. Preparation and in Vitro Studies of Cross-Linked Agarose Beads Entrapped Activated Charcoal (CAAC). Int J Artif Organs 2018. [DOI: 10.1177/039139888100400411] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
A new method for the preparation of the cross-linked agarose beads entrapped activated charcoal (CAAC) is reported. Since the agarose-encapsulated adsorbents reported elsewhere cannot stand high temperature for sterilization, the CAAC has the advantage of thermal stability to withstand autoclave at 121°C. for ½ hour without breaking up or melting. A further advantage of CAAC is that the adsorbent has a much better consistency with good mechanical strength and elasticity, so that it can be formed into beads of a diameter less than 1 mm. This will not only give a better adsorption capacity than larger beads, but can also assure a better blood flow than soft beads which usually interfere in hemoperfusion due to compacting and sludging. Preliminary investigations indicate that the CAAC is relatively hemocompatible.
Collapse
Affiliation(s)
- C.X. Xu
- Artificial Liver Support Research Laboratory Chongqing Medical College People's Republic of China
| | - X.J. Tang
- Artificial Liver Support Research Laboratory Chongqing Medical College People's Republic of China
| | - Z. Niu
- Artificial Liver Support Research Laboratory Chongqing Medical College People's Republic of China
| | - Z.M. Li
- Artificial Liver Support Research Laboratory Chongqing Medical College People's Republic of China
| |
Collapse
|
42
|
Lv Y, Niu Z, Guo X, Yuan F, Liu Y. Serum S100 calcium binding protein A4 (S100A4, metatasin) as a diagnostic and prognostic biomarker in epithelial ovarian cancer. Br J Biomed Sci 2018; 75:88-91. [DOI: 10.1080/09674845.2017.1394052] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Y Lv
- Department of Reproductive Medicine, Qingdao University, Qingdao, China
| | - Z Niu
- Department of Gynaecology, Qingdao University, Qingdao, China
| | - X Guo
- Department of Reproductive Medicine, Qingdao University, Qingdao, China
| | - F Yuan
- Department of Gynaecology, Qingdao University, Qingdao, China
| | - Y Liu
- Department of Reproductive Medicine, Qingdao University, Qingdao, China
| |
Collapse
|
43
|
Anandan C, Cipriani MA, Laughlin RS, Niu Z, Milone M. Rhabdomyolysis and fluctuating asymptomatic hyperCKemia associated with CACNA1S variant. Eur J Neurol 2017; 25:417-419. [PMID: 29193480 DOI: 10.1111/ene.13528] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2017] [Accepted: 11/24/2017] [Indexed: 12/25/2022]
Abstract
BACKGROUND AND PURPOSE CACNA1S encodes Cav 1.1, a voltage sensor for muscle excitation-contraction coupling, which activates the ryanodine receptor 1 (RYR1) leading to calcium release from the sarcoplasmic reticulum. CACNA1S mutations cause hypokalemic periodic paralysis, malignant hyperthermia and congenital myopathy. RYR1 mutations result in congenital myopathy, malignant hyperthermia and rhabdomyolysis. METHODS The aim was to describe a novel phenotype associated with a CACNA1S variant at a site previously linked to hypokalemic periodic paralysis. RESULTS The patient presented with fluctuating asymptomatic creatine kinase elevation after an episode of rhabdomyolysis but has no history of periodic paralysis. His muscle biopsy showed core-like structures occurring mainly in type 2 fibers. He carries a novel Cav 1.1 variant (p.Arg528Leu) affecting a highly conserved amino acid. Different mutations at the same location cause hypokalemic periodic paralysis. CONCLUSION This case underscores the similarity between the phenotypes caused by mutations in two functionally linked proteins, RYR1 and Cav 1.1.
Collapse
Affiliation(s)
- C Anandan
- Department of Neurology, Mayo Clinic, Rochester, MN, USA
| | - M A Cipriani
- Department of Family Medicine, Mayo Clinic, Rochester, MN, USA
| | - R S Laughlin
- Department of Neurology, Mayo Clinic, Rochester, MN, USA
| | - Z Niu
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.,Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA
| | - M Milone
- Department of Neurology, Mayo Clinic, Rochester, MN, USA
| |
Collapse
|
44
|
Ruan B, Zhang B, Chen A, Yuan L, Liang J, Wang M, Zhang Z, Fan J, Yu X, Zhang X, Niu Z, Zheng Y, Gu S, Liu X, Du H, Wang J, Hu X, Gao L, Chen Z, Huang H, Wang X, Sun Q. Cholesterol inhibits entotic cell-in-cell formation and actomyosin contraction. Biochem Biophys Res Commun 2017; 495:1440-1446. [PMID: 29198709 DOI: 10.1016/j.bbrc.2017.11.197] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2017] [Accepted: 11/29/2017] [Indexed: 12/25/2022]
Abstract
Cell-in-cell structure is prevalent in human cancer, and associated with several specific pathophysiological phenomena. Although cell membrane adhesion molecules were found critical for cell-in-cell formation, the roles of other membrane components, such as lipids, remain to be explored. In this study, we attempted to investigate the effects of cholesterol and phospholipids on the formation of cell-in-cell structures by utilizing liposome as a vector. We found that Lipofectamine-2000, the reagent commonly used for routine transfection, could significantly reduce entotic cell-in-cell formation in a cell-specific manner, which is correlated with suppressed actomyosin contraction as indicated by reduced β-actin expression and myosin light chain phosphorylation. The influence on cell-in-cell formation was likely dictated by specific liposome components as some liposomes affected cell-in-cell formation while some others didn't. Screening on a limited number of lipids, the major components of liposome, identified phosphatidylethanolamine (PE), stearamide (SA), lysophosphatidic acid (LPA) and cholesterol (CHOL) as the inhibitors of cell-in-cell formation. Importantly, cholesterol treatment significantly inhibited myosin light chain phosphorylation, which resembles the effect of Lipofectamine-2000, suggesting cholesterol might be partially responsible for liposomes' effects on cell-in-cell formation. Together, our findings supporting a role of membrane lipids and cholesterol in cell-in-cell formation probably via regulating actomyosin contraction.
Collapse
Affiliation(s)
- Banzhan Ruan
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, PR China; Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Bo Zhang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing 100038, PR China
| | - Ang Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Long Yuan
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China; Department of Cardiology, Xiaogan Central Hospital, Hubei 432000, PR China
| | - Jianqing Liang
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, PR China; Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Manna Wang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Zhengrong Zhang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Jie Fan
- Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, PR China
| | - Xiaochen Yu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Xin Zhang
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Zubiao Niu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - You Zheng
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China; State Key Laboratory of Cancer Biology, Xijing Hospital, Xi'an 710032, PR China
| | - Songzhi Gu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Xiaoqing Liu
- Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, PR China
| | - Hongli Du
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, PR China
| | - Jufang Wang
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, PR China
| | - Xianwen Hu
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Lihua Gao
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China
| | - Zhaolie Chen
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China.
| | - Hongyan Huang
- Department of Oncology, Beijing Shijitan Hospital of Capital Medical University, 10 TIEYI Road, Beijing 100038, PR China.
| | - Xiaoning Wang
- School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510000, PR China; The Key Laboratory of Normal Aging & Geriatric, The Chinese PLA General Hospital, Beijing 100853, PR China.
| | - Qiang Sun
- Laboratory of Cell Engineering, Institute of Biotechnology, 20 Dongda Street, Beijing 100071, PR China; State Key Laboratory of Cancer Biology, Xijing Hospital, Xi'an 710032, PR China.
| |
Collapse
|
45
|
Liu Y, Niu Z, Lin X, Tian Y. MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1. Cancer Gene Ther 2017; 24:208-214. [PMID: 28281524 DOI: 10.1038/cgt.2017.6] [Citation(s) in RCA: 43] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2016] [Revised: 01/16/2017] [Accepted: 01/21/2017] [Indexed: 01/07/2023]
Abstract
Cisplatin resistance hinders the efficacy of chemotherapy in ovarian cancer. MicroRNAs (miRs) have been implicated in drug resistance in anti-cancer chemotherapy. We compared the expression profiles of miRs between cisplatin-resistant and cisplatin-sensitive ovarian cancer cells, and found that miR-216b was significantly downregulated in cisplatin-resistant ovarian cancer cells. To investigate its molecular mechanism, we performed cell viability and apoptosis assays in cisplatin-resistant ovarian cells, and found that miR-216b reduced cell viability and promoted apoptosis. Although 4 potential targets were obtained through bioinformatics, only the mRNA level of poly(ADP-ribose) polymerase (PARP)-1 was significantly regulated by miR-216b. Disruption of the complementary binding sequence of miR-216b on the 3'-untranslated region (3'-UTR) of the PARP1 led to the loss of miR-216b targeting. Spearman's correlation coefficient of the levels of miR-216b and PARP1 mRNA from 51 human ovarian cancer specimens also showed a significantly negative correlation between them. Importantly, the improved cisplatin sensitivity induced by miR-216b was markedly reversed by PARP1 overexpression. Tumor formation assay in nude mice further provided an evidence on the suppressive role of miR-216b in tumor growth. Taken together, this study demonstrated that a new miRNA, miR-216b, was involved in cisplatin resistance in ovarian cancer, which could be regarded as a potential sensitizer in cisplatin chemotherapy.
Collapse
Affiliation(s)
- Y Liu
- Department of Obstetrics and Gynecology, Provincial Hospital Affiliated to Shandong University, Jinan, China.,Department of Obstetrics and Gynecology, Liaocheng people's Hospital, Liaocheng, China
| | - Z Niu
- Department of Obstetrics and Gynecology, Liaocheng people's Hospital, Liaocheng, China
| | - X Lin
- Department of Obstetrics and Gynecology, Provincial Hospital Affiliated to Shandong University, Jinan, China
| | - Y Tian
- Department of Obstetrics and Gynecology, Provincial Hospital Affiliated to Shandong University, Jinan, China
| |
Collapse
|
46
|
Niu Z, Hu H, Tang F. High Free Fatty Acid Levels Are Associated with Stroke Recurrence and Poor Functional Outcome in Chinese Patients with Ischemic Stroke. J Nutr Health Aging 2017; 21:1102-1106. [PMID: 29188867 DOI: 10.1007/s12603-016-0852-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
BACKGROUND The aim of this study is to investigate whether serum and cerebrospinal fluid (CSF) free fatty acid (FFA) levels are associated with outcome and recurrence in a cohort of patients with an acute ischemic stroke (AIS). METHODS From December 2013 to May 2015, patients with first-ever AIS were included. FFA level and NIH stroke scale (NIHSS) were measured at the time of admission. Logistic regression analysis was used to evaluate the stroke outcome and recurrence according to FFA level. Clinical follow-up was performed at 6 month. RESULTS In our study, we studied 296 patients (52.7% male). We have found a positive correlation between serum and CSF levels of FFA. Patients with a poor outcome and recurrence had significantly increased FFA serum and CSF levels on admission (all p<0.0001). Multivariate logistic regression analysis adjusted for common risk factors showed that FFA was an independent predictor of poor functional outcome and recurrence. Odds ratios (OR) values were more significant for the higher levels of FFA. CONCLUSION In summary, baseline serum and CSF FFA level were associated with stroke poor function outcome and recurrence, suggesting an effect of FFA on disease course in AIS.
Collapse
Affiliation(s)
- Z Niu
- Fengyun Tang, Department of neurology, Shaoxing center Hospital, No.1, huayu Road Shaoxing, 312030, China, E-mail: ; Tel: 86- 15857597397
| | | | | |
Collapse
|
47
|
Si L, Xu H, Zhou X, Zhang Z, Tian Z, Wang Y, Wu Y, Zhang B, Niu Z, Zhang C, Fu G, Xiao S, Xia Q, Zhang L, Zhou D. Generation of influenza A viruses as live but replication-incompetent virus vaccines. Science 2016; 354:1170-1173. [DOI: 10.1126/science.aah5869] [Citation(s) in RCA: 108] [Impact Index Per Article: 13.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 11/08/2016] [Indexed: 01/16/2023]
|
48
|
Zhu D, Niu Z, Wei Y, Xu J. 176P Robotic anterior resection of rectal cancer without abdominal incision: transanal rectal eversion and resection for specimen extraction: A preliminary and feasibility study. Ann Oncol 2016. [DOI: 10.1016/s0923-7534(21)00334-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
49
|
Zhu D, Niu Z, Wei Y, Xu J. 176P Robotic anterior resection of rectal cancer without abdominal incision: transanal rectal eversion and resection for specimen extraction: A preliminary and feasibility study. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw581.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
50
|
Abstract
Lung cancer is the leading cause of cancer-related mortality in the world, with more than 1 million deaths/year. Over the past years, lung cancer treatment has been based on cytotoxic agents and an improvement in the outcome and quality of life for patients has been observed. However, it has become clear that additional therapeutic strategies are urgently required to provide an improved survival benefit for patients. A major intracellular signaling pathway, the Hippo signaling pathways have been extensively studied in neoplasia, including lung cancer. Furthermore, the study of constitutively activated receptor and their downstream signaling mediators has become a promising new field of investigation for lung cancer treatment. Nevertheless for lung cancer, this approach has not been successful yet. Here, we will review the molecular basis of Hippo signaling in lung cancer and further discuss the therapeutic potential of multi-targeted strategies involving Yes-associated protein inhibitors.
Collapse
Affiliation(s)
| | | | | | | | | | - H Zhang
- Department of Hand Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
| |
Collapse
|